ANDREW P. COMBS,WENQING YAO,YUN-LONG LI,EDDY W. YUE,SONG MEI,WENYU ZHU,JOSEPH GLENN,THOMAS P. MADUSKUIE JR.,RICHARD B. SPARKS,BRENT DOUTY,CHUNHONG HE
申请号：
PT12775861
公开号：
PT2751109T
申请日:
2012.08.31
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
